Related Experiment Video
Updated: Aug 22, 2025

Assessment of Morphine-induced Hyperalgesia and Analgesic Tolerance in Mice Using Thermal and Mechanical Nociceptive Modalities
Published on: July 29, 2014
Opioid toxicity: histamine, hypersensitivity, and MRGPRX2
Brian A Baldo1,2, Nghia H Pham3,4
1Kolling Institute of Medical Research, Royal North Shore Hospital of Sydney, Sydney, NSW, 2065, Australia. babaldo@iinet.net.au.
Research reveals the mast cell receptor MRGPRX2 mediates non-immune drug reactions. Opioid drugs activate MRGPRX2, causing histamine release and adverse effects like flushing. Further studies will clarify the link between MRGPRX2 activation and opioid-induced reactions.
Area of Science:
- Pharmacology
- Immunology
- Dermatology
Background:
- Non-immune drug reactions, including toxicities and pseudoallergies, are common.
- The mast cell receptor MRGPRX2 (mastocyte-related G-protein-coupled receptor member X2) mediates these reactions without antibody involvement.
- Opioid-induced mast cell degranulation, releasing histamine and causing cutaneous effects, is a known MRGPRX2 activation outcome.
Purpose of the Study:
- To investigate the role of MRGPRX2 in mediating adverse reactions to opioid analgesic drugs (OADs).
- To determine if an OAD's histamine-releasing potency correlates with MRGPRX2 activation and adverse cutaneous effects.
Main Methods:
- Utilizing basophil and mast cell tests informed by MRGPRX2 research.
- Employing recently developed methodologies and strategies to assess OAD effects on mast cells.
Main Results:
- MRGPRX2 activation by opioids like morphine, codeine, and dextromethorphan causes mast cell degranulation and histamine release.
- MRGPRX2 exhibits stereochemical preference for dextro-opioid enantiomers.
- OADs vary significantly in their histamine-releasing potency, with fentanyl being a non-releaser and morphine a strong releaser.
Conclusions:
- Understanding MRGPRX2 activation is crucial for explaining non-immune drug hypersensitivities.
- Further research is needed to establish a definitive correlation between OAD-induced histamine release, MRGPRX2 activation, and observed adverse reactions.
More Related Videos
07:48Tracking Drug-induced Changes in Receptor Post-internalization Trafficking by Colocalizational Analysis
Published on: July 3, 2015
16:02Demonstration of the Sequence Alignment to Predict Across Species Susceptibility Tool for Rapid Assessment of Protein Conservation
Published on: February 10, 2023
Related Concept Videos
Opioid Receptors: Overview
Analgesia and Pain Management
Opioid Analgesics: Morphine and Other Natural Cogeners
Opioid Analgesics: Synthetic and Semisynthetic Opioids
Desensitization and Tachyphylaxis
Anticholinesterase Agents: Poisoning and Treatment
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...